You searched for Antibody candidate - Page 18 of 69

Best in Biotech 25 Jan 2024

Eight mental health biotech companies trying to make a difference to people’s lives

…get better faster. The company’s clinical pipeline includes novel drug candidates for depression, post-traumatic stress disorder (PTSD), schizophrenia, and other mental health conditions. It also has its own biomarker platform…

January 25, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

…effect is,” the study read. Depression candidate Supernus’ SPN-820 fails in phase 2b clinical trial; Actinogen blames placebos This was seen with American biotech Supernus Pharmaceuticals’ depression candidate SPN-820, which…

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 30 Jul 2024

Why is the immunology and inflammation market suddenly attracting a wave of investment?

…biomedical advancements in the basic science of immunology combined with productizing therapeutic antibodies enabled the second wave. Here, doctors could finally direct an antibody at a defined immune target, allowing…

July 30, 2024 - 13 minutesmins - By Willow Shah-Neville

News and Trends 4 Jan 2018

Swedish Biotech Pockets $6M as its Cancer Antibody Heads for the Clinic

…to attack tumors by binding the CD40 co-stimulatory molecule on dendritic cells. The antibody may also kill cancer cells directly through a second mechanism. The candidate has already been tested…

January 4, 2018 - 2 minutesmins - By Alex Dale

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

…round of investment in ChemomAb, an Israeli startup developing a monoclonal antibody to treat nonalcoholic steatohepatitis (NASH). ChemomAb’s antibody, CM-101, is fully humanized and targets a newly discovered protein that…

December 5, 2017 - 2 minutesmins - By Evelyn Warner

abbvie bms empliciti multiple myeloma cancer immunooncology ema

News and Trends 13 May 2016

First and only antibody for Multiple Myeloma approved in EU

Bristol-Myers Squibb and AbbVie have announced that their co-development project for an antibody therapy against Multiple Myeloma has been approved in the EU after a successful Phase III trial. Empliciti…

May 13, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 14 Dec 2017

Belgian Biotech Raises $231M to Continue Developing its Antibody Therapies

Argenx has smashed its target of $150M for its US offering, which will support its cancer and autoimmune disease antibodies through the clinic. Argenx develops antibody-based therapies for the treatment…

December 14, 2017 - 1 minutemin - By Alex Dale

News and Trends 18 Jul 2019

Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs

The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M ($506M) IPO to fuel its antibody drug programs in cancer, autoimmune diseases, and more. This…

July 18, 2019 - 2 minutesmins - By Jonathan Smith

inflarx trial inflammatory disease fail skin

More News! 6 Jun 2019

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

…drug didn’t have any effect on the outcome. Hidradenitis suppurativa is a chronic disease that lasts for life and can be difficult to manage. InflaRx’s failed antibody was designed to…

June 6, 2019 - 2 minutesmins - By Jonathan Smith

genmab janssen blood cancer multiple myeloma

News and Trends 11 Jun 2019

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

…needs for patients,” stated the CEO of Genmab, Jan van de Winkel. “Pre-clinical data suggest that [the candidate antibody] could be superior to daratumumab for certain tumor cell types and…

June 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 11 Dec 2017

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

…Phase II trial with ARGX-113 (efgartigimod), in which the antibody therapy has proved to provide a significant improvement in patients with generalized myasthenia gravis, a form of the disease that…

December 11, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 6 Jul 2017

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in…

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Eight mental health biotech companies trying to make a difference to people’s lives

Depression drug trials are failing—and placebos are to blame

Why is the immunology and inflammation market suddenly attracting a wave of investment?

Swedish Biotech Pockets $6M as its Cancer Antibody Heads for the Clinic

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

First and only antibody for Multiple Myeloma approved in EU

Belgian Biotech Raises $231M to Continue Developing its Antibody Therapies

Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!